KALA Stock Analysis: Buy, Sell, or Hold?

KALA - KALA BIO, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.53
-0.01 (-1.85%) ▼
HOLD
MODERATE Confidence
Protect Your KALA Gains
Last Updated: January 30, 2026

Get Alerted When KALA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: KALA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: KALA is currently trading at $0.53, which is considered slightly low relative to its 30-day fair value range of $0.58 to $0.65.

Technical Outlook: Technically, KALA is in a strong downtrend. Immediate support is located at $0.51, while resistance sits at $0.71.

Market Sentiment: KALA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.50 (+177.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $0.58 - $0.65
Company Quality Score 41/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Protect Your Profits

Holding KALA? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 177.8% below Wall St target ($1.50)
  • CAUTION: 5-day price weakness (-12.4%) - monitor closely

Fair Price Analysis

30-Day Fair Range $0.58 - $0.65
Current vs Fair Value SLIGHTLY LOW

Support & Resistance Levels

Support Level $0.51
Resistance Level $0.71
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -1.02
Wall Street Target $1.50 (+177.8%)
Revenue Growth (YoY) -100.0%
Last updated: January 31, 2026 7:43 AM ET
Data refreshes hourly during market hours. Next update: 8:43 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Mary Reumuth SELL 967 shares 2025-10-23
Mark T Iwicki SELL 154894 shares 2025-10-23
Darius Kharabi SELL 20806 shares 2025-10-22

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$66 46 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$112 52 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$90 59 HOLD
RNA
Avidity Biosciences Inc
STRONG BUY
15 analysts
$75 62 BUY
GPCR
Structure Therapeutics I…
STRONG BUY
14 analysts
$108 56 HOLD

Advanced KALA Option Strategies

Professional options setups generated by AI based on today's KALA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for KALA

KALA Technical Chart KALA Price Prediction KALA Investment Advisor KALA Fair Price Analyzer KALA Options Advisor KALA Options Chain KALA Options Analysis KALA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals